GLOBUS MEDICAL INC acquires StelKast, Inc.
Snapshot
GLOBUS MEDICAL INC acquired StelKast, Inc. for approximately $28.4 million net assets (about $24.1 million cash at closing plus up to $4.3 million contingent consideration based on product-sales milestones) in April 2019. The transaction was structured as all cash. StelKast, Inc. is a USA-based Orthopedics — joint reconstruction (knee and hip) business.
- Acquirer
- GLOBUS MEDICAL INC
- Target
- StelKast, Inc.
- Value
- approximately $28.4 million net assets (about $24.1 million cash at closing plus up to $4.3 million contingent consideration based on product-sales milestones)
- Date
- April 2019
- Type
- asset purchase
- Status
- ready
The deal at a glance
About this deal
GLOBUS MEDICAL INC acquired StelKast, Inc. for approximately $28.4 million net assets (about $24.1 million cash at closing plus up to $4.3 million contingent consideration based on product-sales milestones), a transaction completed in April 2019, structured as all cash. The deal was a asset purchase.
StelKast, Inc. operates in Orthopedics — joint reconstruction (knee and hip), is based in USA. StelKast, Inc. is a privately held company that designs, manufactures and distributes orthopedic implants for knee and hip replacement surgeries.
Serves as a platform to expand Globus's products and services into the Total Joint Arthroplasty market, combining its product-development engine and computer-assisted Imaging, Navigation and Robotics technologies with joint-replacement products.
Entry platform into the Total Joint Arthroplasty (knee and hip) market with an established implant portfolio. Integrated into Globus Medical's musculoskeletal portfolio
No advisory firms have been disclosed for this transaction.